Dyadic International, Inc.
DYAI
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antā¦ read more
Healthcare
Biotechnology
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.05
Price-1.87%
-$0.02
1Y
Price
Market Cap
$38.261m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-162.3%
EBITDA Margin-169.7%
Net Profit Margin-159.0%
Free Cash Flow Margin-162.3%
EBITDA Margin-169.7%
Net Profit Margin-159.0%
Free Cash Flow MarginRevenue
$2.975m
-24.8%
1y CAGR-1.8%
3y CAGR+4.2%
5y CAGREarnings
-$7.292m
-26.5%
1y CAGR+6.1%
3y CAGR+10.9%
5y CAGREPS
-$0.21
-20.0%
1y CAGR+8.7%
3y CAGR+13.4%
5y CAGRBook Value
-$407.730k
$7.810m
Assets$8.217m
Liabilities$5.053m
DebtDebt to Assets
64.7%
-0.7x
Debt to EBITDAFree Cash Flow
-$5.716m
-16.4%
1y CAGR+13.8%
3y CAGR+17.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company